INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 111 filers reported holding INHIBRX INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,023,829 | -29.7% | 382,770 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $9,985,644 | +40.7% | 384,655 | +2.2% | 0.00% | 0.0% |
| Q1 2023 | $7,099,272 | +12.1% | 376,220 | +46.4% | 0.00% | 0.0% |
| Q4 2022 | $6,332,924 | +119.1% | 257,018 | +59.6% | 0.00% | – |
| Q3 2022 | $2,890,000 | +81.5% | 161,033 | +14.7% | 0.00% | – |
| Q2 2022 | $1,592,000 | -74.9% | 140,351 | -50.7% | 0.00% | -100.0% |
| Q1 2022 | $6,336,000 | +157.4% | 284,419 | +404.6% | 0.00% | – |
| Q4 2021 | $2,462,000 | +2179.6% | 56,367 | +1624.8% | 0.00% | – |
| Q3 2021 | $108,000 | -85.1% | 3,268 | -87.6% | 0.00% | – |
| Q2 2021 | $724,000 | +2.4% | 26,334 | -25.2% | 0.00% | – |
| Q1 2021 | $707,000 | +248.3% | 35,228 | +471.2% | 0.00% | – |
| Q4 2020 | $203,000 | – | 6,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |